Starling Oncology (STLN) Net Income towards Common Stockholders Growth (1y) (2021 - 2026)
Powered by 
Analysis
Starling Oncology (STLN) Net Income towards Common Stockholders Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn | 2.06% |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn | 186.81% |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn | 12.17% |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | 24.71% |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn | 1.48% |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn | 18.19% |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn | 28.98% |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn | 49.80% |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn | 45.69% |
| 10 | Starling Oncology | 609.95 Mn | 568.85 Mn | 27.17 Mn | 41.10% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.10% |
| Mar 31, 2026 | 86.97% |
| Dec 31, 2025 | 40.63% |
| Sep 30, 2025 | -4.14% |
| Jun 30, 2025 | -10.35% |
| Mar 31, 2025 | 19.18% |
| Dec 31, 2024 | 42.27% |
| Sep 30, 2024 | 24.09% |
| Jun 30, 2024 | 24.96% |
| Mar 31, 2024 | 33.70% |
| Dec 31, 2023 | -70.38% |
| Sep 30, 2023 | -551.42% |
| Jun 30, 2023 | -209.87% |
| Mar 31, 2023 | -255.54% |
| Dec 31, 2022 | -10.80% |
| Sep 30, 2022 | -673.67% |
| Jun 30, 2022 | 10.91% |
| Mar 31, 2022 | 238.35% |
| Dec 31, 2021 | -248,350,400.00% |
| Sep 30, 2021 | 82.12% |